| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/03/2011 | US20110053223 Cell culture methods to make antibodies with enhanced adcc function |
| 03/03/2011 | US20110053222 PC5 as a Factor IX Propeptide Processing Enzyme |
| 03/03/2011 | US20110053221 Recombinant production of authentic human proteins using human cell expression systems |
| 03/03/2011 | US20110053220 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same |
| 03/03/2011 | US20110053219 Method for the Targeted Integration of Multiple Copies of a Gene of Interest in a Yarrowia Strain |
| 03/03/2011 | US20110053218 Multiple promoter platform for protein production |
| 03/03/2011 | US20110053217 Polynucleotides encoding signal peptide-containing molecules |
| 03/03/2011 | US20110053216 Modified Cyanobacteria |
| 03/03/2011 | US20110053215 Endoglycosidases that Cleave O-linked Glycans |
| 03/03/2011 | US20110053214 Production of galactosylated glycoproteins in lower eukaryotes |
| 03/03/2011 | US20110053205 Composition and Methods for Expressing Reporter Molecules in Mammalian Cells |
| 03/03/2011 | US20110053189 Type IV secretion system proteins in sero-detection of Anaplasma phagocytophium |
| 03/03/2011 | US20110052640 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
| 03/03/2011 | US20110052632 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/03/2011 | US20110052617 Aav scleroprotein, production and use thereof |
| 03/03/2011 | US20110052615 Tumour-specific animal proteins |
| 03/03/2011 | US20110052606 Humanized Anti-Human NKG2A Monoclonal Antibody |
| 03/03/2011 | US20110052596 Antibodies to il-17a |
| 03/03/2011 | US20110052595 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 03/03/2011 | US20110052592 Compositions and Methods for Use for Antibodies Against Sclerostin |
| 03/03/2011 | US20110052591 Variants of Thyroid Stimulating Hormone Beta |
| 03/03/2011 | US20110052590 Neutrokine-alpha antibodies and methods of use thereof |
| 03/03/2011 | US20110052582 Humanized Anti-CDCP1 Antibodies |
| 03/03/2011 | US20110052577 Antibodies |
| 03/03/2011 | US20110052572 Regulators of mmp-9 and uses therof |
| 03/03/2011 | US20110052571 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
| 03/03/2011 | US20110052525 Breaking Immunological Tolerance with a Genetically Encoded Unnatural Amino Acid |
| 03/03/2011 | US20110052499 Baboon homolog of human cd147 |
| 03/03/2011 | US20110052493 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
| 03/03/2011 | DE112009001080T5 Verfahren zum Herstellen von β-Alanylaminosäure oder eines Derivats davon A process for producing β-alanyl-amino acid or a derivative thereof |
| 03/02/2011 | EP2290079A2 Neurotrophic factors |
| 03/02/2011 | EP2290077A2 Natural IGM antibodies and inhibitors thereof |
| 03/02/2011 | EP2290062A1 Corynebacterium glutamicum gene encoding phosphoenolpyruvate carboxykinase |
| 03/02/2011 | EP2290053A1 Method for producing Influenza virus in protein-free cell culture medium |
| 03/02/2011 | EP2289943A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody |
| 03/02/2011 | EP2289940A2 Treatment of metastatic disease |
| 03/02/2011 | EP2289550A2 Ultra high affinity neutralizing antibodies |
| 03/02/2011 | EP2289548A2 Combined vaccines comprising hepatitis B surface antigen and other antigens |
| 03/02/2011 | EP2288716A2 Method for producing corn gluten hydrolysate and corn gluten hydrolysate using the same |
| 03/02/2011 | EP2288715A2 Human serum albumin linkers and conjugates thereof |
| 03/02/2011 | EP1495056B1 Methods of analyzing antibody disulfide isomers |
| 03/02/2011 | EP1368456B1 Anti-bacterial vaccine compositions |
| 03/02/2011 | CN1507490B Promoters |
| 03/02/2011 | CN101982546A Process for producing dipeptide |
| 03/01/2011 | USRE42190 Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors |
| 03/01/2011 | US7897842 GnTIII expression in plants |
| 03/01/2011 | US7897742 Nucleotide sequences coding phospholipase; screening and identifying grampositive mocroorganisms |
| 03/01/2011 | US7897733 Rapamycin conjugates and antibodies |
| 03/01/2011 | US7897732 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 03/01/2011 | US7897730 TRAIL receptor-binding agents and uses of the same |
| 03/01/2011 | US7897726 Fluorescent proteins from Aequorea coerulscens and methods for using the same |
| 03/01/2011 | US7897571 Recombinant lubricin molecules and uses thereof |
| 03/01/2011 | US7897385 Fluorescent protein |
| 03/01/2011 | US7897384 Chondrocyte therapeutic delivery system |
| 03/01/2011 | US7897370 Process for producing HMG-CoA reductase inhibitor |
| 03/01/2011 | US7897369 Isoprenoid wax ester synthases, isoprenoid acyl CoA-synthetases, and uses thereof |
| 03/01/2011 | US7897367 Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefore |
| 03/01/2011 | US7897351 Peptides and antibodies to MUC 1 proteins |
| 03/01/2011 | US7897343 Propagating attenuated lelystad agent in host cells for use in generating vaccine for prevention and treatment of procine respiratory infection |
| 03/01/2011 | US7897341 Optical sorting method |
| 03/01/2011 | US7897335 Detection of preferential proteins in sample; obtain sample nucleotide sequences, dilute, amplify sequences, translate, test for proteins |
| 03/01/2011 | US7897332 Immunoglobulin for detecting lymphadenopathy associated viral infections; immunodiagnostics |
| 03/01/2011 | US7897158 Recombinant toxin fragments |
| 03/01/2011 | US7897157 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2339331C Expression and export of angiogenesis inhibitors as immunofusins |
| 02/24/2011 | WO2011022387A1 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility |
| 02/24/2011 | WO2011022339A1 Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents |
| 02/24/2011 | WO2011022335A1 Methods of using cd44 fusion proteins to treat cancer |
| 02/24/2011 | WO2011022077A2 A nucleic acid cassette for producing recombinant antibodies |
| 02/24/2011 | WO2011021616A1 Novel protein having β-glucosidase activity, and use thereof |
| 02/24/2011 | WO2011020155A1 Anti p2x7 receptor antibodies and fragments thereof |
| 02/24/2011 | WO2010129304A3 Method for making heteromultimeric molecules |
| 02/24/2011 | WO2010114615A3 A facile system for encoding unnatural amino acids in mammalian cells |
| 02/24/2011 | WO2009135603A8 Method of generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins |
| 02/24/2011 | US20110047657 Method for generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046054 Anti diabetic protein |
| 02/24/2011 | US20110046011 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 02/24/2011 | US20110045538 Peptide, Use Of The Peptide, Method For The Production Of The Peptide, Solid Support Having The Peptide Immobilized Thereon, And Method For Production Of The Solid Support |
| 02/24/2011 | US20110045537 Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors |
| 02/24/2011 | US20110045536 Mammalian expression vector |
| 02/24/2011 | US20110045535 Activator for Blood Coagulation Factor VII Promoter and Utilization of the Same |
| 02/24/2011 | US20110045534 Nucleic Acid Cassette For Producing Recombinant Antibodies |
| 02/24/2011 | US20110045533 Production of glycosylated polypeptides in micro algae |
| 02/24/2011 | US20110045532 Protein production method |
| 02/24/2011 | US20110045531 Method for producing a recombinant protein on a manufacturing scale |
| 02/24/2011 | US20110045530 Enzymatic conjugation of bioactive moieties |
| 02/24/2011 | US20110045519 Differentiated immortalised cell lines capable of producing albumin and blood coagulation factors, methods of preparing thereof from a leukaemia cell line and uses thereof |
| 02/24/2011 | US20110045513 Protein electron mediator |
| 02/24/2011 | US20110045508 Urinary CA125 Peptides as Biomarkers of Ovarian Cancer |
| 02/24/2011 | US20110045159 Oligosaccharide ingredient |
| 02/24/2011 | US20110045098 Excitatory glycine receptors and methods |
| 02/24/2011 | US20110045017 Hiv vaccine for mucosal delivery |
| 02/24/2011 | US20110045011 TRUNCATED RECOMBINANT MAJOR OUTER MEMBRANE PROTEIN ANTIGEN (R56) OF ORIENTIA TSUTSUGAMUSHI STRAINS KARP, KATO and GILLIAM AND ITS USE IN ANTIBODY BASED DETECTION ASSAYS AND VACCINES |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110044989 Zona Pellucida Binding Peptides, Expression Vectors, Compositions, and Methods for Species Specific Immunocontraception of Animals |
| 02/24/2011 | US20110044986 Anti-amyloid antibodies and uses thereof |
| 02/24/2011 | US20110044980 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 02/24/2011 | US20110044976 Humanized antibodies |